Blue Horseshoe Stocks: Options Update, New Idea & More

Valeant Pharmaceuticals International, Inc. VRX-  Options Update
We wanted to circle back to touch upon an update for the VRX 04/22 $32 Calls we initially slated for observation on Tuesday.  VRX trading activity allowed for us to witness a run from 2.90-3.90 that day, for possible gains of up to 35%

We stated as much in yesterday’s morning report, with the added reminder that we felt certain the scope of those gains would increase, and we were spot-on once again.

For the day we observed a move from 4.25-5.25, a relatively modest 24%, however as measured from the low we saw on Tuesday morning, it marked a two-day swing of 81%, so cheers to those of our readers who were following along with us on this play!

Tesla Motors, Inc. TSLA – New Options Idea

Up until yesterday’s session, TSLA had been enjoying an epic rally which began in early February, however, that began to fizzle out over the past couple of days. The stock now appears very top-heavy, and that was confirmed by a fall below its 200DMA yesterday.

In the event that this is a protracted backsliding event, we’re going to want to be ready with a corresponding options trading idea.  We’re going to zero in on contracts in the range of TSLA March 24th $220-215 Puts, which qualify as Weekly contracts*, as the markets are closed tomorrow.

*Please remember, trading weekly options contracts on a Friday is an extreme high risk/high reward proposition, and is recommended for highly experienced traders only.

Celator Pharmaceuticals, Inc. CPXX

CPXX was a point of focus for us last Wednesday, when we caught a hot PR hitting the wires, and despite the stock already being up considerably at that point, we were able to glean a healthy 41% gain out of the stock that first day (from a low of 6.44).

As we’ve kept observing the play over the course of the week, we’ve seen a continual stream of higher highs and higher lows, which culminated in a new high of 12.64 yesterday. In exactly one week’s time, we saw CPXX make an overall swing totaling 96%

Great Basin Scientific, Inc. GBSN

We also want to give ourselves a quick pat on the back for calling GBSN to our readers attention via our extended watchlist yesterday. The stock was experiencing highly abnormal activity due to some FDA News and despite gapping up to the extreme, we still saw a dip-and-rip which carried the stock on an intraday run from .222-.29, a 31% swing.

Extended Watchlist:

Blue Horseshoe Stocks: Options Updates, Fresh Ideas & More

Apple, Inc. AAPL – Options Update

For the third consecutive session yesterday, we were treated to exceptional intraday performances by the AAPL Weekly $114-116 Calls that we initially signaled on Tuesday.

AAPL continued to bull its way to its highest PPS levels in over two months, and managed to close above $120 on the day. As a result, the contracts we were monitoring provided the following opportunities:

$114 Calls – Daily Range:  4.34-6.70 – Max Gain: 54%
$115 Calls - Daily Range: 3.47-5.70 – Max Gain: 64%
$116 Calls - Daily Range: 2.53-4.70 – Max Gain: 86%

While those gains were respectable, sharp traders will have seen greater opportunities in rolling up their strike prices to stay closer to the money as AAPL continued to run. The stock gapped up to crack the $121-mark in the premarket this morning, and so we’ll definitely be looking for quick-strike chances* in the range of the Weekly $119-121 Calls.

*Just remember, contracts with weekly expiration represent exploding offers. Extreme caution is required for trading these options on Friday!

LinkedIn Corp. LNKD

Speaking of fresh options ideas, LNKD is soaring in the premarket this morning, so we’re going to be tracking a range of contracts in this chain as well. We had tremendous success with LNKD calls this summer, and given the current conditions, we believe history could repeat itself today.

We’ll be prospecting a wide range in the LNKD Weekly $235-245 Calls as the session commences, as it seems that things could get very interesting(…and don’t forget the warning above about trading weeklies on a Friday!).

Extended Watchlist:

Blue Horseshoe Stocks: Special Options Video & More

Huge Options Winners/New Ideas – Special Video Presentation To wrap another excellent trading week, we’re going to do something new. With such huge winners coming from yesterday’s options ideas, and big opportunities coming today, we’ve drawn up a visual aid in the form of an informative and instructive video presentation.

We highly suggest our readers click through to the following special video featuring our very own ‘Stock Sumo’, who succinctly explains how we found huge success with NFLX Calls yesterday, and how we may be able to do the same with GOOG Calls today.


The video outlines the gains on yesterday’s idea of NFLX Weekly $107.00 -111.43 Calls. Every one of the 13 sets contracts in that range exploded for astounding gains. They ranged from the $107.14′s running 508% from 1.52-9.25, to the $111.43′s amazing 3823% jump from a low of .13 to as much as 5.10.

It goes on to mention our options speculations for today’s session. Google is gapping up an earnings beat this morning, and we’ve formulated some corresponding ideas, specifically GOOG Weekly $640-655 Calls. We’ll be looking out for a possible dip-and-rip scenario to come into play.

Trading Weekly contracts on a Friday can be be an exciting proposition when proper caution is exercised. Time-decay becomes a big factor so close to expiration, and premiums evaporate. That tends to lead to more volatile activity, creating an environment in which we thrive.

Voltari Corp. VLTC 

We’ve been tracking VLTC for quite some time, following it to some awesome gains this spring after word got out of billionaire activist investor Carl Icahn’s position in the stock. We re-alerted the stock on Tuesday via our Extended Watchlist, and lo and behold, Icahn’s name would find its way into the VLTC news stream again.

We had to be patient for a couple of sessions, but were ultimately rewarded yesterday with one heck of an intraday move when traders learned that Icahn was still long in the stock. VLTC ran from a low of 5.57 all the way up to 9.00; a 62% swing that came on a little more than five times the 3-month average volume.

Extended Watchlist:

Blue Horseshoe Stocks: PVSP Update, PLUG News & More

Pervasip Corp. PVSP

For the second consecutive session, PVSP made higher highs and higher lows yesterday. We re-focused on this old favorite at the end of last week, and caught it trading at a low of .0014. After a solid session to close out the holiday-shortened week, we once again included it in our premarket report yesterday, and the stock kicked this week off on a strong note as well.

We observed a trading range from .0015 to .0021, a 40% intraday push, and an overall range of 50% over our observed low from Thursday.

The heathly activity on the chart can be attributed in part to last week’s acquisition news; PVSP now holds, through its newly-acquired subsidiary, a 60% stake in Denver-based distribution company servicing the hydroponic and indoor cannabis grow market>> Read PR

Plug Power, Inc. PLUG

Speaking of old favorites, PLUG has published a PR today which is standing out among this morning’s top news items, with a very promising announcement of their Q2 figures. Perhaps one of the most notable aspects; the company shipped more than twice as many of its GenDrive fuel cell units as it did in the previous quarter.

This news comes at an opportune time, with the stock having been undergoing a recent downtrend which culminated in the logging of a new 52-week low yesterday. We’re anxious to follow the activity after what is looking like a significant gap-up this morning, in what could turn into a noteworthy rebound-play.

LATHAM, N.Y., July 7, 2015 (GLOBE NEWSWIRE) — Plug Power Inc. (PLUG), a leader in providing clean, reliable energy solutions, today highlighted strong fuel cell and hydrogen infrastructure shipments and installations in the second quarter of 2015 allowing for a record revenue quarter. The company is on track to achieve its previously announced 2015 financial targets. >> FULL PR

Prima BioMed, Ltd. PBMD

Also cropping up on our news scanner this morning is PBMD. It’s no secret that we’ve had an exceptional amount of success with various pharma plays this year, and this could be the next entry into that group.

This morning’s news suggests that the company’s flagship product, a metastatic breast cancer treatment, could be on the path to approval for European markets. The stock is trading at its lowest price since May.

SYDNEY, AUSTRALIA–(Marketwired – Jul 7, 2015) – Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (“Prima” or the “Company”), a leading immuno-oncology company, is pleased to announce that it has received positive Scientific Advice from the European Medicines Agency (“EMA” or the “Agency”) on the development path for its lead product, IMP321 in metastatic breast cancer. >> FULL PR

Extended Watchlist:
ORMP, JDST, MDBX, KALO(Bottom-Watch), OCFN (Possible Momentum-Play)

Blue Horseshoe Stocks: TSLA Options Recap & More

Tesla Motors, Inc. TSLA – Options

Despite another choppy day for the markets as a whole, we were able to find a diamond in the rough with our TSLA Options Idea in Thursday’s premarket report.

As the stock was gapping up, we identified the possibility of some dip-and-rip scenarios occurring in weekly TSLA $275-280 Calls and that’s precisely what we got. There was some extremely impressive action with the $275′s and $277.50′s in particular, that could’ve provided traders with exponential gains.

The $275 Calls jumped out of the starting gate and went on an initial run from 5.00 to 7.60 (+52%) in the first couple minutes of the session. The dip-and-rip we were after provided an even bigger opportunity as the contracts reached a midday low of .78 before rebounding, and absolutely exploded back to a 5.10 close. That marked a second intraday rip of 554%

The $277.50′s traded in a similar pattern; the initial move was from 3.20 to 5.40 (+69%), and their dip took them to a low of .21 before re-launching as high as 3.00 into the close. That was a mind-boggling 1329% rip.

NuGene International, Inc. NUGN

NUGN has been an ongoing point of interest for us over the past few weeks; we alerted the stock in the third week of June, and at that time, observed a 2.67 swing-low. Since then, the chart has been on a steady incline, surging as much as 47% as it hit a high of 3.88 on both Wednesday and Thursday.

We’ll be looking for the possibility of the stock cracking through that resistance to continue its uptrend into this week.

There’s a fresh PR coming off of the wire this morning as well:

IRVINE, Calif., July 6, 2015 /PRNewswire/ – NuGene International, Inc. (“NuGene”) (NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, conducted one-on-one meetings with top beauty editors in New York City including Allure, Vogue, Glamour, Marie Claire, Self, Shape, More, Town and Country, People, People Style Watch, Cosmopolitan, Better Homes and Gardens and W. >> View PR

Extended Watchlist: